Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
7 Apr 2026 Job Information Organisation/Company Inserm UMR-S 1250 Research Field Biological sciences » Biology Medical sciences » Health sciences Researcher Profile First Stage Researcher (R1
-
. The doctoral research will be conducted within the COMETE laboratory (INSERM U1075) at the University of Caen Normandy and will rely in part on the PrediFall cohort, a multidisciplinary research program
-
to the research work of the HiBAL (Hybrid iPS Bioartificial Liver) project, a task of which is carried out by the BMBI laboratory. The Inserm 1193 laboratory, the project leader, is based at the Hepato-Biliary
-
the demands of the role. These factors help to define the mayor’s external exposome and enable the study of physical and mental health using a holistic approach. This project draws on data from the ECO-MAIRE
-
Host institution: NIMH Unit, Inserm-EPHE-Université de Caen Normandie U1077 (https://nimh.unicaen.fr/fr/accueil/ ) Supervision: Dr Peggy Quinette, Associate Professor in Psychology, Université de Caen
-
11 Mar 2026 Job Information Organisation/Company Sorbonne Université, CNRS, Inserm Department Engineering Research Field Physics » Applied physics Researcher Profile First Stage Researcher (R1
-
10 Mar 2026 Job Information Organisation/Company INSERM 1116 Research Field Medical sciences » Health sciences Biological sciences » Biology Pharmacological sciences » Clinical pharmacology
-
may result in exclusion at the eligibility check or conditional offers being withdrawn. Selection process The selection process follows an open, transparent, merit-based, and equitable procedure, in
-
or contextual factors may explain differences in treatment engagement and outcomes, particularly in chronic physical and mental health conditions that require sustained engagement and self-management. This PhD
-
la recherche médicale (INSERM), France) DC9: Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy (Champalimaud Foundation (CF), Portugal) DC10